Abstract:Growth hormone (GH) receptor (GHR) and (full-length) prolactin (PRL) receptor (PRLR) are transmembrane class I cytokine receptors that co-exist in various normal and cancerous cells. Both receptors respond to their associated ligands predominantly by activating the Janus Kinase 2 (JAK2)-signal transducer and activator of transcription (STAT) signaling pathways, and both are also known to initiate receptor-specific JAK2-independent signaling. Together with their cognate ligands, these receptors have been associated with pro-tumorigenic effects in various cancers, including breast cancer (BC). Human GH is known to bind GHR and PRLR, while PRL can only bind PRLR. A growing body of work suggests that GHR and PRLR can form heteromers in BC cells, modulating GH signal transduction. However, the dynamics of PRLR and GHR on the plasma membrane and how these could affect their respective signaling still need to be understood. To this end, we set out to unravel the spatiotemporal dynamics of GHR and PRLR on the surface of human T47D breast cancer cells and γ2A-JAK2 cells. We applied direct stochastic optical reconstruction microscopy (dSTORM) and quantified the colocalization and availability of both receptors on the plasma membrane at the nanometer scale at different time points following treatment with GH and PRL. In cells co-expressing GHR and PRLR, we surprisingly observed that not only GH but also PRL treatment induces a significant loss of surface GHR. In cells lacking PRLR or expressing a mutant PRLR deficient in JAK2 binding, we observed that GH induces downregulation of cell surface membrane-bound GHR, but PRL no longer induces loss of surface GHR. Colocalizations of GHR and PRLR were confirmed by proximity ligation (PL) assay. Our results suggest that PRLR-GHR interaction, direct or indirect, is indispensable for PRL- but not GH-induced loss of surface GHR and for both GH-induced and PRL-induced increase of surface PRLR, with potential consequences for downstream signaling. Furthermore, our results suggest that JAK2 binding via the receptor intracellular domain's Box1 element is crucial for the observed regulation of one class I cytokine receptor's cell surface availability via ligand-induced activation of another class I cytokine receptor. Our findings shed new light on the reciprocal and collective role that PRLR and GHR play in regulating cell signaling.

Expression of Prolactin Receptor and Response to Prolactin Stimulation of Human Nk Cell Lines

Induction of Preprotachykinin-I and Neurokinin-1 by Adrenocorticotropin and Prolactin. Implication for Neuroendocrine-Immune-hematopoietic Axis

Recombinant Human Prolactin Improves Antitumor Effects of Murine Natural Killer Cells in Vitro and in Vivo

Antitumor Effects of Recombinant Human Prolactin in Human Adenocarcinoma-Bearing SCID Mice with Human NK Cell Xenograft

Prolactin Modulates the Functions of Murine Spleen CD11c-positive Dendritic Cells

Regulatory action of prolactin on the in vitro growth of CD34+ve human hemopoietic progenitor cells

Effects of prolactin and cortisol on natural killer (NK) cell surface expression and function of human natural cytotoxicity receptors (NKp46, NKp44 and NKp30)

Expression of Leptin Receptors and Response to Leptin Stimulation of Human Natural Killer Cell Lines

Prolactin promotes growth of a spontaneous T cell lymphoma: role of tumor and host derived cytokines

IL-2Rα Up-Regulation is Mediated by Latent Membrane Protein 1 and Promotes Lymphomagenesis and Chemotherapy Resistance in Natural Killer/t-Cell Lymphoma

High expression of prolactin receptor is associated with cell survival in cervical cancer cells

Correlational study between prolactin promoting breast cancer cell proliferation and microRNA expression profiling change

Immunomodulatory Effects of Prolactin on Peripheral Blood Lymphocytes

Phospho-proteomics reveals that RSK signaling is required for proliferation of natural killer cells stimulated with IL-2 or IL-15

NK Cell Proliferation Induced by IL-15 Transpresentation Is Negatively Regulated by Inhibitory Receptors

Expansion and Function of Human NK Cells Induced with Different Stimulating Factor Combinations Ex Vivo

A role for JAK2 in mediating cell surface GHR-PRLR interaction

Neuregulin 4 (Nrg4) cooperates with melatonin to regulate the PRL expression via ErbB4/Erk signaling pathway as a potential prolactin (PRL) regulator

Receptor Activator of NF-κB Ligand Induction Via Jak2 and Stat5a in Mammary Epithelial Cells

Human Prolactin Promotes Human Secondary Immunoglobulin Response in Human/SCID Mouse Chimeras

The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors